Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.

作者: Keith D. Green , Sylvie Garneau-Tsodikova

DOI: 10.1021/ACS.JMEDCHEM.5B01375

关键词:

摘要: Cationic amphiphiles derived from aminoglycosides (AGs) have been shown to exhibit enhanced antimicrobial activity. Through the attachment of hydrophobic residues such as linear alkyl chains on AG backbone, interesting antibacterial and antifungal agents with a novel mechanism action developed. Herein, we report design synthesis seven kanamycin B (KANB) derivatives. Their activities, along resistance/enzymatic, hemolytic, cytotoxicity assays were also studied. Two these compounds, C12 C14 aliphatic chain attached at 6″-position KANB through thioether linkage, exhibited good activity, poorer substrates than for several AG-modifying enzymes, could delay development resistance in bacteria fungi. Also, they both relatively less hemolytic known membrane targeting antibiotic gramicidin agent amphotericin not toxic their MIC values. oxidation sulfones was demonstrated no effect activities. Moreover, acted synergistically posaconazole, an azole currently used treatment human fungal infections.

参考文章(47)
SK Shrestha, M Grilley, T Anderson, C Dhiman, J Oblad, T Chang, K Sorensen, JY. Takemoto, In vitroantifungal synergy between amphiphilic aminoglycoside K20 and azoles againstCandida species and Cryptococcus neoformans Medical Mycology. ,vol. 53, pp. 837- 844 ,(2015) , 10.1093/MMY/MYV063
A.H. Groll, T.J. Walsh, Uncommon opportunistic fungi: new nosocomial threats Clinical Microbiology and Infection. ,vol. 7, pp. 8- 24 ,(2001) , 10.1111/J.1469-0691.2001.TB00005.X
Sanjib K Shrestha, Marina Y Fosso, Keith D Green, Sylvie Garneau-Tsodikova, None, Amphiphilic tobramycin analogues as antibacterial and antifungal agents Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 4861- 4869 ,(2015) , 10.1128/AAC.00229-15
Smritilekha Bera, George G Zhanel, Frank Schweizer, None, Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity. Journal of Medicinal Chemistry. ,vol. 51, pp. 6160- 6164 ,(2008) , 10.1021/JM800345U
Ramesh Dhondikubeer, Smritilekha Bera, George G Zhanel, Frank Schweizer, None, Antibacterial activity of amphiphilic tobramycin. The Journal of Antibiotics. ,vol. 65, pp. 495- 498 ,(2012) , 10.1038/JA.2012.59
Ido M. Herzog, Keith D. Green, Yifat Berkov-Zrihen, Mark Feldman, Roee R. Vidavski, Anat Eldar-Boock, Ronit Satchi-Fainaro, Avigdor Eldar, Sylvie Garneau-Tsodikova, Micha Fridman, 6′′‐Thioether Tobramycin Analogues: Towards Selective Targeting of Bacterial Membranes Angewandte Chemie. ,vol. 51, pp. 5652- 5656 ,(2012) , 10.1002/ANIE.201200761
Wenjing Chen, Keith D. Green, Oleg V. Tsodikov, Sylvie Garneau-Tsodikova, Aminoglycoside multiacetylating activity of the enhanced intracellular survival protein from Mycobacterium smegmatis and its inhibition. Biochemistry. ,vol. 51, pp. 4959- 4967 ,(2012) , 10.1021/BI3004473
A. Van Schepdael, J. Delcourt, M. Mulier, R. Busson, L. Verbist, H. J. Vanderhaeghe, M. P. Mingeot-Leclercq, P. M. Tulkens, P. J. Claes, New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation Journal of Medicinal Chemistry. ,vol. 34, pp. 1468- 1475 ,(1991) , 10.1021/JM00108A035
A. Makovitzki, D. Avrahami, Y. Shai, Ultrashort antibacterial and antifungal lipopeptides Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 15997- 16002 ,(2006) , 10.1073/PNAS.0606129103